BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone Apr 13, 2021
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders Jan 15, 2021
BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study Nov 16, 2020
BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans Oct 13, 2020
BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic May 22, 2020
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic Apr 10, 2020
